Answers are grounded in this paper and cite their sources.
Meeting abstracts Montanide ISA 51 VG and Montanide ISA 720 VG are two novel adjuvants dedicated to human therapeutic vaccines. They have been used in more than 200 clinical trials involving cancer, AIDS, malaria or autoimmune disease vaccines and involving an accrual of more than 20000 patients.
No takes yet. Share an insight, caveat, or question.
Ascarateil et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: